ADC抗体内吞检测试剂
应用（Application）
Antibody Internalization Detection Reagent (Cat. No. IGG-PZF2001) is formed by conjugating anti-human Fc antibody with a pH-sensitive red fluorescent dye. It can be used to assess the endocytosis of antibodies by labeling the human IgG Fc region. After co-incubation with the target antibody, a stable fluorescent complex can be formed to detect the endocytosis of the antibody in the cells. Furthermore, with the pH-sensitive dye, not only can it significantly enhance the fluorescence signal in an acidic environment, but also prevent the background noise.
特异性（Specificity）
Specifically recognizes the human antibody Fc portion.
检测波长（Detection Wavelength）
Excitation Wavelength: 643 nm
Emission Wavelength: 660 nm
存储（Storage）
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 24 months in lyophilized state;
-20°C to -70°C for 12 months after reconstitution.
关键字： ADC抗体内吞检测试剂;内吞检测试剂;ADC内吞检测试剂;ACRO;百普赛斯;
百普赛斯集团ACROBiosystems Group（股票代码：301080）是成立于2010年的跨国生物科技公司，是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球，横跨亚洲、北美洲、欧洲，在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家，与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。